These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 12379918)

  • 1. The relative rates of glutamine and asparagine deamidation in glucagon fragment 22-29 under acidic conditions.
    Joshi AB; Kirsch LE
    J Pharm Sci; 2002 Nov; 91(11):2331-45. PubMed ID: 12379918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The estimation of glutaminyl deamidation and aspartyl cleavage rates in glucagon.
    Joshi AB; Kirsch LE
    Int J Pharm; 2004 Apr; 273(1-2):213-9. PubMed ID: 15010145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the mechanism of aspartic acid cleavage and glutamine deamidation in the acidic degradation of glucagon.
    Joshi AB; Sawai M; Kearney WR; Kirsch LE
    J Pharm Sci; 2005 Sep; 94(9):1912-27. PubMed ID: 16052557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The stability and degradation pathway of recombinant human parathyroid hormone: deamidation of asparaginyl residue and peptide bond cleavage at aspartyl and asparaginyl residues.
    Nabuchi Y; Fujiwara E; Kuboniwa H; Asoh Y; Ushio H
    Pharm Res; 1997 Dec; 14(12):1685-90. PubMed ID: 9453054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of a histidine residue on the C-terminal side of an asparaginyl residue on the rate of deamidation using model pentapeptides.
    Goolcharran C; Stauffer LL; Cleland JL; Borchardt RT
    J Pharm Sci; 2000 Jun; 89(6):818-25. PubMed ID: 10824141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemical pathways of peptide degradation. II. Kinetics of deamidation of an asparaginyl residue in a model hexapeptide.
    Patel K; Borchardt RT
    Pharm Res; 1990 Jul; 7(7):703-11. PubMed ID: 2395797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical pathways of peptide degradation. III. Effect of primary sequence on the pathways of deamidation of asparaginyl residues in hexapeptides.
    Patel K; Borchardt RT
    Pharm Res; 1990 Aug; 7(8):787-93. PubMed ID: 2235875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing the extent of bone degradation using glutamine deamidation in collagen.
    Wilson J; van Doorn NL; Collins MJ
    Anal Chem; 2012 Nov; 84(21):9041-8. PubMed ID: 23030643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of asparagine 330 deamidation in an Fc-fragment of IgG1 using cation exchange chromatography and peptide mapping.
    Zhang YT; Hu J; Pace AL; Wong R; Wang YJ; Kao YH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Aug; 965():65-71. PubMed ID: 24999246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The degradation pathways of glucagon in acidic solutions.
    Joshi AB; Rus E; Kirsch LE
    Int J Pharm; 2000 Aug; 203(1-2):115-25. PubMed ID: 10967434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo deamidation characterization of monoclonal antibody by LC/MS/MS.
    Huang L; Lu J; Wroblewski VJ; Beals JM; Riggin RM
    Anal Chem; 2005 Mar; 77(5):1432-9. PubMed ID: 15732928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deamidation of Asn-143 of gamma S crystallin from protein aggregates of the human lens.
    Takemoto L
    Curr Eye Res; 2001 Feb; 22(2):148-53. PubMed ID: 11402392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of acidic N + 1 residues on asparagine deamidation rates in solution and in the solid state.
    Li B; Gorman EM; Moore KD; Williams T; Schowen RL; Topp EM; Borchardt RT
    J Pharm Sci; 2005 Mar; 94(3):666-75. PubMed ID: 15668945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of amino acid sequence, buffers, and ionic strength on the rate and mechanism of deamidation of asparagine residues in small peptides.
    Tyler-Cross R; Schirch V
    J Biol Chem; 1991 Nov; 266(33):22549-56. PubMed ID: 1939272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low levels of asparagine deamidation can have a dramatic effect on aggregation of amyloidogenic peptides: implications for the study of amyloid formation.
    Nilsson MR; Driscoll M; Raleigh DP
    Protein Sci; 2002 Feb; 11(2):342-9. PubMed ID: 11790844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Degradation of aspartic acid and asparagine residues in human growth hormone-releasing factor.
    Bongers J; Heimer EP; Lambros T; Pan YC; Campbell RM; Felix AM
    Int J Pept Protein Res; 1992 Apr; 39(4):364-74. PubMed ID: 1428526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment method for deamidation in proteins using carboxylic acid derivatization-liquid chromatography-tandem mass spectrometry.
    Kawasue S; Sakaguchi Y; Koga R; Yoshida H; Nohta H
    J Pharm Biomed Anal; 2020 Mar; 181():113095. PubMed ID: 31962249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonenzymatic deamidation of asparaginyl and glutaminyl residues in proteins.
    Wright HT
    Crit Rev Biochem Mol Biol; 1991; 26(1):1-52. PubMed ID: 1678690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of asparagine deamidation in a SOD1-based biosynthetic human insulin precursor by MALDI-TOF mass spectrometry.
    Bierczyńska-Krzysik A; Łopaciuk M; Pawlak-Morka R; Stadnik D
    Acta Biochim Pol; 2014; 61(2):349-57. PubMed ID: 24936522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased deamidation of asparagine during human senile cataractogenesis.
    Takemoto L; Boyle D
    Mol Vis; 2000 Sep; 6():164-8. PubMed ID: 10976112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.